
Sign up to save your podcasts
Or
In this video, Dr. Jones breaks down the urgent situation surrounding access to compounded GLP-1 medications like semaglutide and tirzepatide. With FDA enforcement looming and compounded versions technically already removed, many patients could soon find themselves without access to affordable options. Dr. Jones shares real-world insights from coaching thousands of patients, including the story of Jane, who experienced dramatic weight regain after losing access to her medication. More importantly, he explains how to build GLP-1 independence — with tools like microdosing, lifestyle interventions, and improving insulin sensitivity — so you're not caught off guard if compounded meds disappear. If you’re currently on GLP-1 therapy or thinking about it, this video will help you understand the landscape, the risks, and the steps you can take now to protect your health.
5
99 ratings
In this video, Dr. Jones breaks down the urgent situation surrounding access to compounded GLP-1 medications like semaglutide and tirzepatide. With FDA enforcement looming and compounded versions technically already removed, many patients could soon find themselves without access to affordable options. Dr. Jones shares real-world insights from coaching thousands of patients, including the story of Jane, who experienced dramatic weight regain after losing access to her medication. More importantly, he explains how to build GLP-1 independence — with tools like microdosing, lifestyle interventions, and improving insulin sensitivity — so you're not caught off guard if compounded meds disappear. If you’re currently on GLP-1 therapy or thinking about it, this video will help you understand the landscape, the risks, and the steps you can take now to protect your health.
7,248 Listeners
1,091 Listeners
1,126 Listeners
1,204 Listeners
340 Listeners
76 Listeners
517 Listeners
285 Listeners
1,078 Listeners
1,636 Listeners
377 Listeners
78 Listeners
208 Listeners
183 Listeners
242 Listeners